The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 828.00
Bid: 832.00
Ask: 834.00
Change: -4.00 (-0.48%)
Spread: 2.00 (0.24%)
Open: 850.00
High: 850.00
Low: 828.00
Prev. Close: 832.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

24 May 2023 07:00

RNS Number : 4155A
Mortgage Advice Bureau (Hldgs) PLC
24 May 2023
 

24 May 2023

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"In an ongoing challenging environment, we continue to demonstrate the strength of MAB's model and resilience in adviser numbers and mortgage completions against a significantly weaker market backdrop. This positions the Group well for subsequent market recovery.

"Our Adviser numbers have stabilised in Q2 at 2,1221 advisers on 19 May 2023. We expect our existing Appointed Representative firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves further when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty. Our pipeline of incoming new Appointed Representatives has grown strongly this year.

"As expected, the value of completions in the wider market was slower in Q1 2023 with a 21% reduction in new mortgage lending2 compared to last year. MAB's total mortgage completions for Q1 2023 were broadly stable at £5.8bn (2022: £5.9bn). Our new mortgage completions were £4.4bn (2022: £4.9bn) with the balance of £1.4bn (2022: £1.0bn) being Product Transfers. We have continued to grow our market share, which has been achieved despite a reduction in the number of advisers since Q4 2022.

"During the six months following the mini-budget, new mortgage approvals across the market were down by as much as 40% versus the prior year. There are early signs of increasing activity and mortgage approval levels have now gradually started to improve, but remain significantly lower than for the equivalent period last year.

"MAB's performance, despite challenging market conditions, remains in line with the Board's expectations with further improvement expected in the second-half of the year."

 

1 Includes 139 Fluent advisers as at 19 May 2023 (76 advisers in the first charge mortgages division, 49 in the secured personal loans division, 8 in the later life division, and 6 in the bridging finance division). Includes a total of 183 advisers at 19 May 2023 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 UK Finance, product transfer lending figures not available until 7 June.

 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

 

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Numis Securities Limited

Stephen Westgate / Giles Rolls

 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFWDEDSEEI
Date   Source Headline
14th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSCompletion of acquisition of The Fluent Money Grp
5th Jul 20227:00 amRNSAcquisition of The Fluent Money Group
30th Jun 20222:03 pmRNSDirectors' Shareholdings and PDMR notification
15th Jun 20225:29 pmRNSDirectors' Shareholdings and PDMR notification
10th Jun 20221:23 pmRNSBlock listing Interim Review
8th Jun 20225:47 pmRNSGrant of Options and PDMR Dealing
6th Jun 202212:36 pmRNSDirectors' Shareholdings and PDMR notification
25th May 20223:38 pmRNSResult of AGM
25th May 20227:00 amRNSAGM Statement
16th May 20226:15 pmRNSDirectors' Shareholdings and PDMR notification
29th Apr 20221:10 pmRNSDirectors' Shareholdings and PDMR notification
28th Apr 20228:53 amRNSHolding(s) in Company
25th Apr 20225:13 pmRNSPosting of Report and Accounts and Notice of AGM
20th Apr 202210:29 amRNSDirectors' Shareholdings and PDMR notification
4th Apr 20227:00 amRNSHolding(s) in Company
31st Mar 20224:53 pmRNSDirectors' Shareholdings and PDMR notification
29th Mar 20227:32 amRNSResults of Placing
28th Mar 20225:29 pmRNSProposed Equity Placing
28th Mar 20225:29 pmRNSAcquisition of The Fluent Money Group
28th Mar 20225:29 pmRNSFinal Results for the year ended 31 December 2021
18th Mar 20224:36 pmRNSPrice Monitoring Extension
17th Mar 20224:47 pmRNSHolding(s) in Company
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20224:19 pmRNSDirectors' Shareholdings and PDMR notification
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20224:20 pmRNSHolding(s) in Company
28th Feb 20223:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Feb 20224:06 pmRNSDirector/PDMR Shareholding
31st Jan 20222:19 pmRNSDirectors' Shareholdings and PDMR notification
27th Jan 20227:00 amRNSTrading Update
14th Jan 20223:51 pmRNSDirectors' Shareholdings and PDMR notification
6th Jan 20221:26 pmRNSDirectors' Shareholdings and PDMR notification
21st Dec 20218:54 amRNSHolding(s) in Company
15th Dec 20213:49 pmRNSDirectors' Shareholdings and PDMR notification
10th Dec 202112:00 pmRNSBlock listing Interim Review
8th Dec 20212:34 pmRNSHolding(s) in Company
30th Nov 20212:18 pmRNSDirectors' Shareholdings and PDMR notification
19th Nov 20215:37 pmRNSPDMR dealing
15th Nov 20213:36 pmRNSDirectors' Shareholdings and PDMR notification
1st Nov 20212:34 pmRNSDirectors' Shareholdings and PDMR notification
29th Oct 20212:18 pmRNSDirectors' Shareholdings and PDMR notification
26th Oct 20218:36 amRNSHolding(s) in Company
14th Oct 20214:43 pmRNSDirectors' Shareholdings and PDMR notification
30th Sep 202111:33 amRNSDirectors' Shareholdings and PDMR notification
28th Sep 20217:00 amRNSInterim Results
15th Sep 202112:24 pmRNSDirectors' Shareholdings and PDMR notification
31st Aug 20212:19 pmRNSDirectors' Shareholdings and PDMR notification
17th Aug 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.